A study of the dynamics and genetics of COVID-19 through machine learning by Basu, Sayantani
c© 2020 Sayantani Basu
A STUDY OF THE DYNAMICS AND GENETICS OF COVID-19 THROUGH
MACHINE LEARNING
BY
SAYANTANI BASU
THESIS
Submitted in partial fulfillment of the requirements
for the degree of Master of Science in Computer Science
in the Graduate College of the
University of Illinois at Urbana-Champaign, 2020
Urbana, Illinois
Adviser:
Professor Roy H. Campbell
ABSTRACT
COrona VIrus Disease (COVID-19), a disease caused due to the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV2) resulted in over 12 million infections and over 560,000
deaths in a worldwide pandemic. Countries all over the world carried out mitigation measures
to curb the pandemic in forms of lockdowns, disinfection measures, and social distancing.
We aim to study the dynamics of this disease by using a machine learning based approach
using Long Short-Term Memory (LSTM) in order to evaluate the degree to which the virus
spread. Our model is trained on accumulated COVID-19 cases and deaths. Parameters in
our model can be adjusted to obtain predictions as required. Results have been obtained
at both the country and county levels for the United States of America and some globally
affected areas. We show predictions up to three different points of time – May 11, June 10,
and June 30. We have also carried out a quantitative evaluation of mitigation measures in
eight different counties in the United States depending on the rate of difference between a
short and long window parameter based on the proposed LSTM model. The proposed LSTM
model provides useful insights and can be a useful aid for various places planning strategies
for mitigation and reopening. We aim to study the genetics of COVID-19 using a Multi-Layer
Perceptron (MLP) model to recognize and classify COVID-19 genetic sequences at various
taxonomic levels. Our model is an alignment-free method based on machine learning and
natural language processing techniques that achieves reasonable performance in terms of
cross-validation accuracy and time compared to the baseline model. The results from this
work could potentially contribute to society during the current global concern.
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CHAPTER 1: INTRODUCTION
A novel coronavirus outbreak that spread from China in December 2019 and turned into
a pandemic led to infections and fatalities worldwide. At present, it is estimated that over
12 million people have been infected with COVID-19 and over 560,000 people have died
from contracting the virus [3]. The virus was termed the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV2) and the corresponding disease was termed the COrona VIrus
Disease (COVID-19). Most commonly observed symptoms are cough and fever, with several
patients in severe condition showing pneumonia-like symptoms and dyspnea [4]. Studies
have established that COVID-19 spreads through particles of infected respiratory droplets
that are transmitted from an infected to a healthy person [5]. A range of similar symptoms in
humans have also been observed, including connections to skin rashes [6] and gastrointestinal
symptoms [7]. Several recent studies have studied probable zoonotic pathways, as well as
other species that are capable of contracting COVID-19 [8].
There is no specific cure for COVID-19, although efforts all around the globe are currently
in progress for developing a vaccine or drugs targeted at treating COVID-19. Present treat-
ment methods have made use of antiviral medicines used for treating other viral diseases
[9, 10, 11, 12].
In order to take steps for treating this viral and contagious disease, healthcare profession-
als were provided with special equipment to treat patients infected with COVID-19. This
led to an increase in demand for PPE (Personal Protective Equipment) for frontline health-
care workers in places with high COVID-19 hospitalizations, and for ventilators required in
hospitals [13, 14].
Globally, countries have enforced mitigation measures for COVID-19, which commonly
included total lockdowns, social distancing, and advising people to take precautions like
washing hands, sanitizing surfaces, and wearing face masks. Such decisions were carried
out based on statistical models and projections showcasing the effects of various mitigation
measures [15, 16, 17].
Individuals showing mild COVID-19 symptoms were generally asked to self-isolate for a
period of two weeks and obtain medical help in the event that their health conditions wors-
ened [18, 19, 20]. In several cohort-based studies, COVID-19 was shown to affect particular
groups of people in various populations [21, 22], as well as people having pre-existing medical
conditions [23, 24].
Asymptomatic transmission was considered to be another possible route of infection trans-
mission. In other words, asymptomatic COVID-19 individuals are those who test positive
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for COVID-19 without exhibiting any visible symptoms [25]. This may have accelerated the
spread of COVID-19 [26] as asymptomatic people may not be aware and may have spread
the disease through social interactions with healthy individuals.
In this thesis, we propose machine learning approaches to study the dynamics and genetics
of COVID-19. The rest of this thesis is organized as follows: Chapter 2 discusses related
work on machine learning approaches for COVID-19, Chapter 3 gives some background on
diseases, epidemics, pandemics, and mitigation measures, Chapter 4 elaborates our proposed
methods, Chapter 5 discusses our results for our models on the dynamics and genetics of
COVID-19 while Chapter 6 concludes this thesis.
The work in this thesis has led to the following papers:
[1] S. Basu and R. H. Campbell, “Going by the numbers: learning and modeling COVID-19
disease dynamics”, Chaos, Solitons & Fractals, July 2020, doi: 10.1016/j.chaos.2020.110140.
[2] S. Basu and R. H. Campbell, “Going by the numbers: learning and modeling COVID-19
disease dynamics”, medRxiv, 2020.
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CHAPTER 2: RELATED WORK
2.1 MODELING-BASED APPROACHES FOR COVID-19
The increased incidence of COVID-19 prompted research efforts for studying different
aspects of the disease. In this section, we discuss work related to machine learning and other
similar approaches for COVID-19.
Many previously proposed methods have modeled predictions of how COVID-19 infections
can possibly spread based on statistical approaches. Neher et al. [27] have obtained an SIR
based seasonal transmissability model [28], a category of epidemiological models than can
be used to predict the direction taken by the virus for causing infections in the future.
They have considered infection, population turnover rates, and emigration respectively in
their proposed approach. A more refined version of their method [29] visualizes the hospital
capacity needed to be able to accommodate patients during COVID-19.
Similarly, another hospital impact model CHIME (COVID-19 Hospital Impact Model for
Epidemics) proposed by Penn Medicine [30] predicts the projection of the number of hospi-
talizations, patients requiring ICU (Intensive Care Unit) care and ventilators respectively for
Penn hospitals. They have formulated a statistics-based approach depending on parameters
like hospitalization rate, social contact and detection probability.
Another category of projection models for studying COVID-19 involves machine learning
based approaches by different research teams in a global effort to study the various facets of
the disease.
Hu et al. [31] have proposed an auto-encoder based learning model to forecast cumulative
cases of COVID-19 in China until April 2020 by training on cumulative data from previous
months. They have also carried out a cluster study by grouping the cities and provinces
based on extracted features. Other LSTM approaches have also considered patient data [32]
as well in order to forecast epidemic curves in China [33].
So far, all proposed COVID-19 projection and forecast models have been centered on
graphical analyses and epidemic trajectory prediction. However, in our proposed approach,
we obtain useful insights based on model predictions and also seek to quantitatively evaluate
the degree to which mitigation measures are working depending on the projected trajectories
for COVID-19.
Several other learning models have incorporated image and prescription data to carry
out automated detection of COVID-19 in patients. Wang et al. [34] have studied the
“Traditional Chinese Medicine (TCM)” model using a deep learning based “Ontology-based
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Side-effect Prediction Framework (OSPF)”. Their model comprised an Artificial Neural
Network (ANN) model of three hidden layers that was applied to TCM prescriptions for
treating patients diagnosed with COVID-19. They also validated their proposed OSPF
model in order to measure the safety and effectiveness of using prescriptions from treating
other flu-like illnesses and applying them to treat COVID-19 patients. Any TCM prescription
is classified as ‘Safe’ or ‘Unsafe’ by their proposed model. Additionally, they recognized seven
TCM prescriptions that are more important compared to others for the treatment of patients
diagnosed with COVID-19.
Wang et al. [35] have proposed a GRU (Gated Recurrent Unit) model that has attention
and bidirectionality BI-AT-GRU that is able to classify six types of respiratory patterns
in COVID-19 patients. They have noted that breathing problems in COVID-19 patients
arise predominantly as a result of ‘Tachypnea’, which corresponds to irregular shallow and
rapid breathing. Their proposed model can distinguish among respiratory patterns of ‘Eup-
nea’, ‘Tachypnea’, ‘Cheyne-Stokes’, ‘Central-Apnea’, ‘Biots’, and ‘Bradypnea’ with high F-1
values.
Wang et al. [36] have proposed ‘Inception Migration Neuro Network’, which is a CNN
(Convolutional Neural Network) model to obtain radiography features from volumetric chest
CT (Computer Tomography) scans of patients from two medical institutes in China. Their
proposed model identifies the presence or absence of COVID-19 in a chest CT scan. They
have studied the F1 and AUC (Area Under Curve) scores for their proposed model. More-
over, they claim their proposed method is low cost and non-invasive in nature.
Another similar approach DeepPneumonia by Song et al. [37] used deep learning for
studying CT images of patients with COVID-19. They collected lung CT images for patients
from two hospitals in China for bacterial pneumonia, COVID-19, and healthy patients. Their
proposed method has a sensitivity of 0.93 and an AUC score of 0.99 for classifying COVID-19.
Li et al. [38] have proposed ‘COVNet’ (‘COVID-19 detection neural network’), a deep
learning approach capable of identifying COVID-19 from ‘CAP (Community Acquired Pneu-
monia)’ and other non-pneumonia diseases based on CT scans of patients. The architecture
of their proposed model included max-pooling, ResNet50, and a fully connected layer. Their
main aim was to distinguish COVID-19 features from the images.
Sethy and Behera [39] have proposed a similar machine learning model for X-Ray images
based on ResNet50 and SVM (Support Vector Machines) in order to identify patients with
COVID-19. They have evaluated the efficiency of their proposed model using False Positive
Rate (FPR), F1, Kappa, and MCC (Matthews correlation coefficient) metrics.
We now shift our discussion to genetically classifying COVID-19 based on its genomic
signature. The classic approach to finding genetic similarities among sequences would be to
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use alignment techniques. However, while such methods provide significant accuracies, they
are demanding in terms of computational resources [40]. Several alignment-free methods
have been previously proposed [41, 42] in order to overcome such limitations. One such
approach involves the use of machine learning to classify genes at various taxonomic levels
with reasonable accuracy and does not require alignment. This recently proposed approach
by Randhawa et al. [43] used a digital signal process approach combined with machine
learning as well as a decision tree classifier to obtain a model for classifying COVID-19
sequences. They have evaluated their model in terms of the cross-validation accuracy on 29
COVID-19 sequences (available as of January 27, 2020) and time (in seconds).
In this thesis, we explore an LSTM-based approach for learning the epidemiological dy-
namics of COVID-19. Statistical learning models need rigorous settings of data and tuning
of coefficients to be capable of epidemiological predictions. On the other hand, machine
learning methods enable learning complex patterns automatically from data depending on
the proposed model and its corresponding tuned hyperparameters. This is immensely ap-
plicable to time-series epidemiological data in the case of COVID-19 where the cumulative
values of infections and deaths change with regard to location and time. We then show
results on a neural network model for classifying COVID-19 genetic sequences at various
taxonomic levels. We compare our performance with a recently proposed method [43] as
baseline and show that our model improves on cross-validation accuracy and reduces time
for several test cases on various taxonomic levels, while performing at par on the original
test dataset of COVID-19 sequences. We additionally provide results on a similar sample
from recently available sequences (available as of June 30, 2020) for comparison purposes.
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CHAPTER 3: BACKGROUND
3.1 DISEASE, EPIDEMICS AND PANDEMICS
3.1.1 Disease
A disease is defined as the disruption in ordinary biological functioning of any organism.
Diseases can be caused due to a variety of infectious agents like viruses, bacteria, fungi,
multicellular organisms like mosquitoes and wasps, or due to genetic factors like inheri-
tance and mutation. In the context of this thesis, we discuss COVID-19 (COrona VIrus
Disease), which is a disease caused by the virus severe acute respiratory syndrome coron-
avirus 2 (SARS-CoV2). The original source of transmission of the disease was observed to be
zoonotic, which means animal to human transmission. However, ultimately human-to-human
transmission led to propagation of the disease worldwide. COVID-19 is believed to spread
from droplet infection or direct contact as indicated by clinical studies [44, 45, 46, 47, 48].
3.1.2 Epidemics and Pandemics
An epidemic is a occurrence of a disease in a widespread fashion at a given point in time
that can affect several individuals of a population.
A pandemic is a kind of epidemic which spreads widely over several countries and affects
a significant number of people.
Historically, humans have been subjected to several epidemic outbreaks due to diseases
which have often led to a significant number of global infections and deaths. A summary is
provided in Table 3.1 for the number of deaths worldwide, type, time period, place of origin,
cause, and spread for each disease.
For comparison purposes, we also consider epidemics from the family of coronaviruses like
MERS and SARS and include the COVID-19 outbreak for reference. It is noteworthy that
most recent disease outbreaks have been viral in nature.
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3.2 APPROACHES FOR FIGHTING COVID-19
The following subsections describe general methods for fighting similar epidemics, however,
the discussion is carried out specifically with regard to COVID-19 [49] in this context.
3.2.1 Do Nothing
If no action is taken, people get infected more and more leading to an increase in the death
rate. Moreover, this can also contribute to additional burdens on hospitals and other health-
care facilities who are suddenly faced with the challenge of accommodating large crowds of
infected people. There is also a belief that doing nothing will lead to the population be-
coming immune due to the presence of antibodies obtained by contracting viruses or getting
vaccination, which in turn leads to the phenomenon of “herd immunity” [50, 51, 52] and the
consequent diminishing of such epidemics.
Additionally, there arises the phenomenon of “collateral damage” [53], where people suf-
fering from other ailments cannot receive proper and timely treatment due to increased
attention towards COVID-19 patients in such a scenario.
3.2.2 Mitigation
In this scenario, damage reduction for COVID-19 is carried out in terms of social distancing
and frequent sanitizing so that the infections do not reach their peak and place considerable
strain on the healthcare system. The end goal in this scenario is to just “flatten the curve”
[54, 55, 56].
3.2.3 Suppression
This is an approach to control the spread of the COVID-19 epidemic by following strict
social distancing measures and lockdowns, followed by reopening measures to enable people
to get back to their normal life. While this is able to curb the infections and ease the
burden on the healthcare systems, it puts pressure on people by ordering them to follow
strict measures including face coverings, frequent sanitizing, and so on [57, 58]. Extended
periods of lockdowns are also harmful for the economy of any country [59, 60].
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3.2.4 The Hammer and the Dance
The ‘Hammer and the Dance’ [49, 61, 62] strategy involves acting quickly in the first
few weeks to ‘hammer’ the COVID-19 virus by enforcing strict lockdowns and other strong
mitigation measures. Once this controls surges in the virus, it can be followed by the ‘dance’
for a prolonged time, which involves relaxing mitigation measures to a certain extent and
conducting phased reopening in an effort to control the virus until medications or vaccines
are formulated.
3.2.5 Rapid Testing and Contact Tracing
This is a control measure supported widely by its proponents [63, 64, 65]. Even if social
distancing and lockdowns are implemented, testing is equally important in order to obtain
an idea of the proportions of the population that are affected by the virus. Due to the
contagious nature of COVID-19, rapid testing ensures that people who test positive for
the virus can quickly be isolated to prevent the infection from spreading to other people.
Moreover, contact tracing should also be carried out to identify individuals who have come in
close contact with an infected person and possibly isolating them as they are also potential
carriers of COVID-19.
10
CHAPTER 4: PROPOSED METHODS
4.1 APPROACHES ON MODELING DISEASES
In this section, we discuss a set of approaches for modeling disease propagation that
usually consists of time-series data. We also discuss Multi-layer Perceptron that we used for
classifying COVID-19 sequences.
Long Short-Term Memory Networks (LSTMs)
Originally proposed by Hochreiter and Schmidhuber [66], Long Short-Term Memory Net-
works (LSTMs) are a category of Recurrent Neural Networks (RNNs) capable of capturing
and ‘remembering’ long-term dependencies [67]. These advantages motivated us to use this
approach for our proposed model on COVID-19 dynamics.
Figure 4.1 shows the structure of an LSTM cell with connections for forming an entire
network used for learning, where xt indicates the input at time t, ft indicates the forget
gate, it indicates the input gate, ot indicates the output gate, ct−1 and ct indicate the states
at time t − 1 and t respectively, ht−1 denotes the output from the previous LSTM cell, ht
denotes the output to the next LSTM cell, and c˜t denotes the candidate value of cell state.
Figure 4.1: Structure of LSTM cell with adjoining connections for the LSTM network
11
The equations below summarize the operations occurring in an LSTM. Equations are based
on the original LSTM model [66, 67]. The b term indicates the bias for the corresponding
LSTM gates. The w and u terms indicate the weights for the input and recurrent layers
respectively.
ft = σ(wfxt + ufht−1 + bf ) (4.1)
it = σ(wixt + uiht−1 + bi) (4.2)
ot = σ(woxt + uoht−1 + bo) (4.3)
c˜t = tanh(wcxt + ucht−1 + bc) (4.4)
ct = ft · ct−1 + it · c˜t (4.5)
ht = ot · tanh(ct) (4.6)
Bayesian Inference on SIR
Bayesian Inference can be applied to an SIR model for modeling disease spread. The
SIR model for disease propagation includes Susceptible (S), Infected (I), and Recovered (R)
sections of the population. N represents the total population size, γ and β represent the
recovery and infection rate respectively, Λ represents the cumulative deaths, ρ represents
the fraction of population at risk, η represents the probability of death and Rt−ψ represents
the population removed with delay. In this context, R0 represents the ratio between the
frequency of contacts to that of recovery. The equations for the model adopted from recently
proposed work [68, 69] are stated below.
dS
dt
= −βIS
N
(4.7)
dI
dt
=
βIS
N
− γI (4.8)
dR
dt
= γI (4.9)
N = S + I +R (4.10)
Λt = ρηRt−ψ (4.11)
The equations below from recently proposed work [68, 69] represent Bayesian inference on
the SIR model. α indicates the probability of accepting the parameters.
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log(θ?) ∼ N (log θ? | log θ, σId) (4.12)
logp(Λ1:T , θ
? | y1:T ) = log p(θ) +
T∑
t=1
log (Poisson(yt | Λt)) (4.13)
α = min
(
1,
p(Λ1:T , θ
? | y1:T )
p(Λ1:T , θ | y1:T )
)
(4.14)
Time Series Regression (TSR)
The traditional Time Series Regression (TSR) model for modeling infectious diseases is
represented by the equations below [70]. xt represents the variable that varies according to
time, β, β0, and βp represent the regression coefficients, zp,t represents the risk factors, and
f(t) represents the time function.
Yt ∼ Poisson(µt) (4.15)
log(µt) = β0 + βxt +
∑
p
βpzp,t + f(t) (4.16)
Multilayer Perceptron (MLP)
We now discuss Multilayer Perceptron (MLP), a type of feedforward neural network that
we use for our proposed model on classifying COVID-19 genetic sequences at various taxo-
nomic levels. Figure 4.2 shows an example of a network with two hidden layers drawn using
NN-SVG [71]. Based on a set of inputs, the task of the MLP is to learn to predict the out-
put. The MLP consists of several units called ‘neurons’ which perform weighted summations
followed by an activation function (for example, sigmoid or tanh). It uses a process called
backpropagation [72] for training and performs optimization by minimizing a loss function
like the cross-entropy loss function.
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Figure 4.2: Example of an MLP with two hidden layers
The equations for classification performed by an MLP trained using backpropagation based
on softmax and cross-entropy error are summarized below [72, 73]. yi indicates the softmax
activation at output i, E denotes cross-entropy error, ∂E
∂wji
indicates the gradient for the top
layer weights and ∂E
∂s1j
indicates the gradient for the hidden layer units.
yi =
esi∑nclass
c e
sc
(4.17)
E = −
nclass∑
i
tilog(yi) (4.18)
∂E
∂wji
= (yi − ti)hj (4.19)
∂E
∂s1j
=
nclass∑
i
(yi − ti)wjihj(1− hj) (4.20)
4.2 PROPOSED METHOD ON COVID-19 DYNAMICS
In our proposed method, we use LSTMs to observe the disease dynamics and apply it
to the forecast of cases and deaths of COVID-19. The innate nature of LSTMs enables us
to gain an insight into future predictions of COVID-19 and how it can aid precautionary
mitigation measures in healthcare.
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4.2.1 Dataset
In order to train, validate and test our proposed LSTM model, we obtain publicly available
data from the Johns Hopkins University repository [74]. The repository provides time-series
COVID-19 data for cumulative confirmed cases and deaths for the United States of America
(USA) and other global locations. For our experiments, we show results of COVID-19
predictions on country-level data as well as fine-grained county-level data. We conduct
these experiments due to the variability of the data at different places that provides a rich
environment for study. Additionally, for eight locations in the United States, we evaluate
the effectiveness of mitigation measures based on our proposed LSTM model.
For experimental purposes, we consider data over three periods of time, namely from
January 22 to May 11, from January 22 to June 10, and from January 22 to June 30. These
periods of time are particularly significant in the USA as they indicate the first COVID-19
surge, reopenings, and the second COVID-19 surge respectively. For the sake of uniformity,
we have conducted experiments on all three time intervals for all locations considered as
part of this thesis.
When time series data is separated into train, validation, and test sets, caution has to
be exercised in order to maintain temporal relations. For infectious diseases, the disease
propagates over time, resulting in time-series data of the cumulative numbers of cases and
deaths. As a result, in order to predict the cumulative infections or deaths at a certain point
in time, the model would have to be trained on the preceding time steps.
Simultaneously, tasks like monitoring the generalization and performing hyperparame-
ter selection have to be carried out for the model. To handle this situation, the data is
partitioned on time as shown in Figure 4.3 for training and validation.
Separately, the data is trained on three consecutive splits of train and validation data for
various hyperparameters to obtain the minimum total root mean squared error (RMSE) on
the validation sets. We specially focus on tuning the lookback and lookahead parameters or
windows. The dataset split on train and validation sets for the model is considered to be
80:20 ratio approximately depending on the initial lookback and lookahead parameters of 1
and 1 respectively. However, the model can handle other splits depending on the data as
well. Smaller splits on the train and validation data have approximately been considered at
a 60:20 ratio. For the purpose of our experiments, the lookback parameter is tested between
1 and 7 and the lookahead parameter is tested between 5 and 7 in order to obtain reasonable
future predictions. All parameters have been tested while maintaining constraints on indices
of the train, validation, and test sets.
15
Figure 4.3: Splitting data for the proposed LSTM model
4.2.2 Model Design
The Python framework Keras [75] was used with the backend as TensorFlow in the pro-
posed LSTM model.
For all experiments, the LSTM has 10 layers and is trained for 10,000 epochs with batch
size 10. Normalization is carried out on the logarithmic scale and Adam [76] is used with
learning rate 0.001 for the optimizer. These parameters have been fixed based on validation
performance. The parameters tuned in particular are the window parameters lookback
and lookahead depending on specific location data. Specifically, in this situation, lookback
indicates window size for the consecutive days the LSTM is required to “look back” before
providing a prediction. The lookahead parameter denotes the forthcoming days the model
has to “look ahead” before making a prediction for a date in the future. Both parameters
are used on the respective data (training, validation, and test) by index slicing formulated
as data[:-(lookahead)] divided into sets of lookback days according to time for the input of
the model and data[(lookback+lookahead):] for the output of the model.
The model is generally able to project future predictions of cumulative COVID-19 con-
firmed cases or deaths. For research purposes, we plot and compare the predicted values
after training on the tuned hyperparameters and the actual values of cumulative confirmed
cases or deaths for those particular dates in order to obtain suitable interpretations. All our
analyses of the results and figures for various locations are discussed in depth in Section 5.1.
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4.3 PROPOSED METHOD ON COVID-19 GENETICS
A recently proposed approach for identifying COVID-19 sequences using a machine learn-
ing based alignment-free method [43] used machine learning models in conjunction with a
decision tree classifier to yield results. However, their approach consumes time for some
test cases even though the test results are very accurate. We propose a machine learning
approach using neural networks to train and test for COVID-19 genetic sequences. Like all
the sequences used in the baseline method [43], we obtain our data from SourceForge [77],
NCBI, and GISAID.
In our proposed method, we use the value of k as 7 for the k-mers and 10-fold cross
validation in order to compare our results with that of the baseline method [43]. In the
processing steps, we eliminate any ‘N’ bases from the remaining nucleotides – ‘A’, ‘C’, ‘T’,
and ‘G’. We then use a natural language processing approach to convert the sequences
into a ‘genetic language’ using CountVectorizer to extract unigrams of 7-mers or sets of
seven contiguous DNA nucleotides from each genetic sequence. Each of these vectors is
then normalized with StandardScaler and principal component analysis (PCA) is applied
to reduce the vectors to a length of 100 each or the size of the training set, whichever is
smaller, in order to accommodate for finer taxonomic classification. Our neural network
model is a Multilayer Perceptron with 4 hidden layers of size 80 trained for 1000 iterations
fixed based on experimentation. We use the Python library scikit-learn [78] for the proposed
neural network model. All parameters have been tuned based on experimentation. We now
elaborate each of the tests carried out for our experiments below that are adopted from the
baseline method [43]:
1. Test-1 : Model trained and cross-validated on Adenoviridae, Anelloviridae, Caudovi-
rales, Geminiviridae, Genomoviridae, Microviridae, Ortervirales, Papillomaviridae,
Parvoviridae, Polydnaviridae, Polyomaviridae, and Riboviria sequences. For testing,
COVID-19 sequences should be classified as Riboviria.
2. Test-2 : Model trained and cross-validated on Betaflexiviridae, Bromoviridae, Cali-
civiridae, Coronaviridae, Flaviviridae, Peribunyaviridae, Phenuiviridae, Picornaviri-
dae, Potyviridae, Reoviridae, Rhabdoviridae, and Secoviridae sequences. For testing,
COVID-19 sequences should be classified as Coronaviridae.
3. Test-3a : Model trained and cross-validated on Alphacoronavirus, Betacoronavirus,
Deltacoronavirus, and Gammacoronavirus sequences. For testing, COVID-19 sequences
should be classified as Betacoronavirus.
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4. Test-3b : Model trained and cross-validated on a smaller subset with same proportions
of Alphacoronavirus, Betacoronavirus, and Deltacoronavirus sequences. For testing,
COVID-19 sequences should be classified as Betacoronavirus.
5. Test-4 : Model trained and cross-validated on Embecovirus, Merbecovirus, Nobecovirus,
and Sarbecovirus. For testing, COVID-19 sequences should be classified as Sarbe-
covirus.
6. Test-5 : Model trained and cross-validated on Embecovirus, Merbecovirus, Nobecovirus,
Sarbecovirus, and COVID-19 virus.
7. Test-6 : Model trained and cross-validated on Sarbecovirus and COVID-19 virus.
All our results are discussed in Section 5.2.
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CHAPTER 5: EXPERIMENTS AND RESULTS
5.1 RESULTS ON COVID-19 DYNAMICS
Our results based on our proposed LSTM model are discussed in two main parts: (i) the
prediction models showing predictions of COVID-19 cumulative confirmed cases and deaths
for the United States (at the country and county levels) and other globally affected areas
and (ii) comparative evaluations on mitigation measures for several affected US counties in
the current situation. For all our graphs, dates in January, February, March, April, May,
and June have been prefixed with ‘J’, ‘F’, ‘M’, ‘A’, ‘MA’, and ‘JU’ respectively followed by
the day of that particular month.
For all the graphs, we plot the predicted values and actual values, as well as a baseline
that is computed as the moving average for all actual values over the lookback window.
In general, we observed that predicting the cumulative comfirmed cases resulted in higher
RMSE values when compared to the RMSE values of the predicted cumulative deaths. We
also observed shorter values of lookback and lookahead brought about lower values for both
train RMSE and test RMSE. In our proposed LSTM model, it is of more interest to interpret
the LSTM predictions instead of entirely studying RMSE values. Our experimental results
show the predictability of COVID-19 using the LSTM model with differing window sizes.
In this context, we base our discussion on mitigation measures – if the actual values exceed
those of the LSTM model, we observe that mitigation measures have not worked well and
if the actual values are identical to or less than those of the LSTM model, we observe that
the mitigation measures have worked well. Our experiments indicate that mitigation factors
introduce a perturbation based on what has been learnt. However, there are also several
other factors like effects of the weather, holidays, and new tests for the COVID-19 virus that
may contribute to an increase in infections.
5.1.1 Prediction Models
Prediction Models for the United States of America and Other Globally Affected Areas
We begin by showing results obtained for the United States of America and other locations
affected globally, namely (in order from current higher incidence of COVID-19 infections to
flatter curves), (i) United States, (ii) India, (iii) Japan, (iv) Italy, and (v) Hubei, China. The
COVID-19 cumulative confirmed cases as on June 30, 2020 for these considered locations
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have been plotted on the map as shown in Figure 5.1. All maps have been generated using
the Python plotly library [79].
Figure 5.1: World map showing COVID-19 cases for US and other countries being studied
The plots of training and predictions for cumulative COVID-19 confirmed cases and deaths
in the United States of America are shown in Figure 5.2. The United States differed in
lockdown and phased reopening strategies depending on the various states [80]. COVID-19
predictions on cumulative cases suggest the cases are still rising. Actual COVID-19 cases
in the nation are also increasing. The LSTM predictions for deaths show a slight flattening
trend compared to the COVID-19 cases. All the curves suggest that stronger measures may
need to be continued in order to curb infections.
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Figure 5.2: Predictions for the United States of America
The plots of training and predictions for cumulative COVID-19 confirmed cases and deaths
in India are shown in Figure 5.3. Nationwide lockdowns were carried out in India in many
phases based on the order of March 24 [81]. The predicted cumulative infections show that
the mitigation measures are working, though stronger enforcement may be needed to lower
the rate of incidence of cases. More measures are also needed for deaths that show an
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increasing trend compared to the predictions.
Figure 5.3: Predictions for India
The plots of training and predictions for cumulative COVID-19 confirmed cases and deaths
in Japan are shown in Figure 5.4. Several mitigation measures were implemented in Japan
in March 2020 to curb COVID-19 propagation [82]. The small increase in actual cases
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in contrast to the flattening shown by the LSTM predictions denotes that the mitigation
measures have not yet fully worked. The LSTM predictions on deaths have a trend similar
to the confirmed cases.
Figure 5.4: Predictions for Japan
The plots of training and predictions for cumulative COVID-19 confirmed cases and deaths
in Italy are shown in Figure 5.5. Italy carried out strict lockdowns in various areas begin-
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ning February 23 [83]. The LSTM predictions show the same flattening trend compared
to the actual cumulative COVID-19 cases that implies the mitigation measures have been
successful. The LSTM model is capable of predicting the flattened curve as achieved by
Italy. The deaths in Italy show flattening similar to that of the cases. The slight deviation
for the predictions indicates that some mitigation measures may still be needed.
Figure 5.5: Predictions for Italy
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The plots of training and predictions for cumulative COVID-19 confirmed cases and deaths
in Hubei, China are shown in Figure 5.6, where COVID-19 was initially observed in Wuhan
City [27]. They implemented mitigation measures in January [84]. The flattened curves
suggest measures have worked. Similar trends occur for deaths but some enforcement may
be needed.
Figure 5.6: Predictions for Hubei, China
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Prediction Models for Counties Within the United States
We now discuss results obtained for counties within the United States of America that
were affected during COVID-19, namely (in order from current higher incidence of COVID-19
infections to flatter curves), (i) Los Angeles, California, (ii) Dallas, Texas, (iii) Hillsborough,
Florida, (iv) Maricopa, Arizona, (v) King, Washington, (vi) Fulton, Georgia, (vii) Cook,
Illinois, and (viii) New York City, New York. The COVID-19 cumulative confirmed cases
as on June 30, 2020 for these considered locations have been plotted on the respective state
maps. All state maps have been generated using the Python plotly library [79]. We discuss
strategies and mitigation measures based on varying lockdown and reopening strategies in
different states [85].
Figure 5.8 shows the plots of predictions for COVID-19 confirmed cases and deaths in Los
Angeles, California shown in the map in Figure 5.7. The cases and deaths continually show
a rise which is captured by the LSTM predictions as more data is introduced. However,
the predictions show a slight divergence from the actual curve, which indicates that more
mitigation measures may be necessary.
Figure 5.7: Map highlighting Los Angeles, California
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Figure 5.8: Predictions for Los Angeles, California
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Figure 5.10 shows the plots of predictions for COVID-19 confirmed cases and deaths in
Dallas, Texas shown in the map in Figure 5.9. In this case too, the LSTM learns the trend
better with introduction of more data. Cases and deaths are shown to be rising by the
end of June, which is indicated by both the actual and predicted curves. However, stronger
mitigation measures may need to be introduced in this case as well since the actual values
are well above the LSTM predictions by the end of June.
Figure 5.9: Map highlighting Dallas, Texas
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Figure 5.10: Predictions for Dallas, Texas
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Figure 5.12 shows the plots of predictions for COVID-19 confirmed cases and deaths in
Hillsborough, Florida shown in the map in Figure 5.11. The cases show a rising trend that
is captured by both the actual and predicted LSTM curves. However, for deaths, there
is considerable divergence between the actual and predicted curves. This indicates further
need of implementing stronger mitigation measures.
Figure 5.11: Map highlighting Hillsborough, Florida
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Figure 5.12: Predictions for Hillsborough, Florida
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Figure 5.14 shows the plots of predictions for COVID-19 confirmed cases and deaths in
Maricopa, Arizona shown in the map in Figure 5.13. Arizona showed a sudden rise in cases
in June. As indicated by the LSTM predictions and actual cases, till June 10, the mitigation
measures were working though there was a steady rise in cases. However, by June 30, the
divergence between actual and predicted curves for both predictions and deaths show that
mitigation measures did not work for the later part of June.
Figure 5.13: Map highlighting Maricopa, Arizona
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Figure 5.14: Predictions for Maricopa, Arizona
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Figure 5.16 shows the plots of predictions for COVID-19 confirmed cases and deaths in
King, Washington shown in the map in Figure 5.15. The plots indicate that the increase
in mitigation measures were working well until the last week of June, which is shown by a
slight divergence between the LSTM and actual curves in both infections and deaths.
Figure 5.15: Map highlighting King, Washington
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Figure 5.16: Predictions for King, Washington
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Figure 5.18 shows the plots of predictions for COVID-19 confirmed cases and deaths in
Fulton, Georgia shown in the map in Figure 5.17. Based on the graphs, the mitigation
measures are working in terms of the deaths but not for infections as indicated by the
divergence in late June.
Figure 5.17: Map highlighting Fulton, Georgia
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Figure 5.18: Predictions for Fulton, Georgia
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Figure 5.20 shows the plots of predictions for COVID-19 confirmed cases and deaths in
Cook, Illinois shown in the map in Figure 5.19. The predictions are able to capture the
trend of flattening for both cases and deaths. The mitigation measures are working for both
cases and deaths based on the graphs. However, the slight increasing trend for both cases
and deaths indicates that prolonged mitigation measures may be required.
Figure 5.19: Map highlighting Cook, Illinois
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Figure 5.20: Predictions for Cook, Illinois
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Figure 5.22 shows the plots of predictions for COVID-19 confirmed cases and deaths in
New York City, New York shown in the map in Figure 5.21. New York was one of the
most severely affected areas of the United States. Counties in New York implemented
lockdowns in March [80]. The actual and predicted curves indicate a flattening of the curve
for both infections and deaths. However, while mitigation measures are working based on the
infections, the slight divergence between the LSTM predictions and actual values for deaths
indicates that more measures may need to be enforced before completely lifting restrictions.
Figure 5.21: Map highlighting New York City, New York
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Figure 5.22: Predictions for New York City, New York
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5.1.2 How Well are Social Distancing and Other Mitigation Measures Working?
We now evaluate the present mitigation measures in various counties in the United States.
The aim is to evaluate whether the current mitigation measures have worked for the better
or worse. The models discussed are the results generated from our proposed LSTM model.
To begin, we consider two different window sizes – a shorter and a longer window size.
For this purpose, the lookback parameter is fixed as 1 and the line of best fit is computed
on the rate of change of the difference between a smaller lookahead parameter of 1 and a
larger lookahead parameter of 5. These analyses can additionally be performed on individual
parameters. In this context, for experimental purposes the rate on the difference is computed
so that a smoother curve is obtained. For these analyses too, the model can be extended for
the near future. This model is valuable for specific locations to make decisions on whether
to tighten or loosen their lockdown policies based on the degree to which the mitigation
measures are working.
Figure 5.23 and Figure 5.24 show the various plots measuring the extent to which miti-
gation measures are working on rates of COVID-19 infections and deaths in eight different
counties in the United States: (i) Los Angeles, California, (ii) Dallas, Texas, (iii) Hillsbor-
ough, Florida, (iv) Maricopa, Arizona, (v) King, Washington, (vi) Fulton, Georgia, (vii)
Cook, Illinois, and (viii) New York City, New York. The best fit plots denote the line of
best fit in each figure whereas the LSTM rate plots denote the computed rate of difference
between the two LSTM models as mentioned earlier. The line of best fit provides important
insights on the degree to which mitigation measures are currently working based on data till
June 30.
The slope denotes the direction in which mitigation measures are trending – a positive
slope means current social distancing and mitigation measures are not working well while
a negative slope means the current measures are working as expected. A positive slope
denotes a rise in the rate of infections or deaths while a negative slope denotes a fall in the
rate of infections or deaths. The intercept provides an approximate estimate of the increase
or decrease in the rate of infections or the rate of deaths based on a positive or negative
value. The RMSE value provides an approximation of whether the rates of infections or
deaths have stabilized.
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(a) Rate of COVID-19 Infections in Los Angeles,
California
(b) Rate of COVID-19 Deaths in Los Angeles,
California
(c) Rate of COVID-19 Infections in Dallas, Texas (d) Rate of COVID-19 Deaths in Dallas, Texas
(e) Rate of COVID-19 Infections in Hillsborough,
Florida
(f) Rate of COVID-19 Deaths in Hillsborough,
Florida
(g) Rate of COVID-19 Infections in Maricopa,
Arizona
(h) Rate of COVID-19 Deaths in Maricopa, Ari-
zona
Figure 5.23: Evaluating effects of mitigation measures in various counties in the United
States
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(a) Rate of COVID-19 Infections in King, Wash-
ington
(b) Rate of COVID-19 Deaths in King, Washing-
ton
(c) Rate of COVID-19 Infections in Fulton, Geor-
gia
(d) Rate of COVID-19 Deaths in Fulton, Georgia
(e) Rate of COVID-19 Infections in Cook, Illinois (f) Rate of COVID-19 Deaths in Cook, Illinois
(g) Rate of COVID-19 Infections in New York
City, New York
(h) Rate of COVID-19 Deaths in New York City,
New York
Figure 5.24: (Continued) Evaluating effects of mitigation measures in various counties in
the United States
In order to provide a quantified evaluation of the degree to which mitigation measures and
social distancing are working, we compare the slope, intercept, and RMSE values of the line
of best fit for the counties as shown in Table 5.1.
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Table 5.1: Comparing effects of mitigation measures in various counties in the United States
County
Mitigation Measures
for COVID-19
Infections
Mitigation Measures
for COVID-19
Deaths
Slope Intercept RMSE Slope Intercept RMSE
Los Angeles, California 16.31 -22.57 617.21 -0.25 7.00 15.47
Dallas, Texas -6.07 10.01 100.17 0.08 -0.38 3.73
Hillsborough, Florida 4.98 8.58 134.57 -0.03 0.31 1.97
Maricopa, Arizona -10.73 165.94 409.28 0.08 2.44 5.97
King, Washington 1.52 -1.80 24.73 -0.00 0.27 2.19
Fulton, Georgia 1.94 1.65 44.21 -0.02 0.25 4.36
Cook, Illinois 10.78 -160.34 97.76 -0.37 1.80 21.24
New York City, New York 1.14 35.57 65.40 -0.24 6.99 5.89
Mitigation measures have not worked in Los Angeles, California based on the positive rate
of infections even though the rate of deaths is slightly slowing down. Similar to Los Angeles,
California, mitigation measures have not worked in Hillsborough, Florida and Fulton, Geor-
gia as indicated by the positive rate of infections even though the rate of deaths is slightly
slowing down. The same trends are also observed in Cook, Illinois and New York City, New
York, which continue to show rising infection rate trends during the second COVID-19 surge.
King, Washington, shows a rising trend of infection rates though the death rates seem to be
stable. Though Dallas, Texas and Maricopa, Arizona show decreasing trends for infection
rates, the increasing trends for death rates show that the mitigation measures are not yet
working as expected. A noteworthy trend is that COVID-19 death rates are declining or
almost close to stabilization based on the eight counties in the United States being consid-
ered. This occurred because of rapid increase in testing and better treatment provided at
hospitals, that brought down the mortality rate and increased the recovery rate.
High fluctuations or variations in infections or deaths as observed based on high RMSE
values for infection rates in Los Angeles, California and Maricopa, Arizona denote that
reopening measures may need to be considered carefully as the infection or deaths rates
have not yet stabilized well at such locations.
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Table 5.2: Evaluation of mitigation measures in various counties in the United States
County
Success of
Mitigation Measures
based on COVID-19
Infections
Success of
Mitigation Measures
based on COVID-19
Deaths
Los Angeles, California 7 3
Dallas, Texas 3 7
Hillsborough, Florida 7 3
Maricopa, Arizona 3 7
King, Washington 7 3
Fulton, Georgia 7 3
Cook, Illinois 7 3
New York City, New York 7 3
Table 5.2 compares the success of mitigation measures for COVID-19 infections and deaths,
where 3 denotes mitigation measures being successful and 7 denotes mitigation measures
not being successful. Table 5.2 gives an overall view of the success of mitigation measures
depending on the analyses carried out in Table 5.1.
Therefore, different effects and evaluations of mitigation measures have been studied in
various parts of the United States. Mitigation measures in various places may still need
contact tracing, phased reopening, and rapid testing before a regular lifestyle can be resumed.
5.2 RESULTS ON COVID-19 GENETICS
We now discuss our results on classification of COVID-19 genetic sequences at various
taxonomic levels. Table 5.3 and Table 5.4 show our results compared with the baseline
model [43] on their original set of 29 COVID-19 sequences and our randomly sampled set
of 29 COVID-19 sequences respectively. We consider only full length gene sequences for all
our experiments. All cross-validation (CV) accuracies are denoted in percentages and time
in seconds. Our proposed model gives better cross-validation accuracy compared to the
baseline for Test-1, Test-2 and Test-4 as shown in Table 5.3 and for Test-1, Test-2, Test-4,
and Test-5 as shown in Table 5.4. Our proposed method also takes lesser time compared to
the baseline for Test-1, Test-2, Test-3a, and Test-3b as shown in Table 5.3 and for Test-1,
Test-2, and Test-3b as shown in Table 5.4. For all tests, our model performs at par with the
baseline in terms of test results.
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Table 5.3: Comparison of Proposed Model with the Baseline Model [43] on 29 COVID-19
sequences as of January 27, 2020
Train
Data
Test
Data
CV
Baseline
CV
Proposed
Test
Baseline
Test
Proposed
Time
Baseline
Time
Proposed
Test-1 COVID-19 95.0 98.3 100 100 323.33 138.43
Test-2 COVID-19 93.1 97.8 100 100 222.86 109.74
Test-3a COVID-19 98.1 96.1 100 100 11.95 10.62
Test-3b COVID-19 100 96.7 100 100 5.56 3.96
Test-4 COVID-19 98.4 100.0 100 100 5.48 7.06
Test-5 COVID-19 98.7 98.0 - - 2.86 8.34
Test-6 COVID-19 100.0 100.0 - - 2.14 4.89
Table 5.4: Comparison of Proposed Model with the Baseline Model [43] on 29 sampled
COVID-19 sequences as of June 30, 2020
Train
Data
Test
Data
CV
Baseline
CV
Proposed
Test
Baseline
Test
Proposed
Time
Baseline
Time
Proposed
Test-1 COVID-19 95.0 98.35 100 100 323.33 127.48
Test-2 COVID-19 93.1 97.94 100 100 222.86 97.72
Test-3a COVID-19 98.1 98.07 100 100 11.95 13.38
Test-3b COVID-19 100 98.33 100 100 5.56 4.14
Test-4 COVID-19 98.4 100.0 100 100 5.48 8.41
Test-5 COVID-19 98.7 99.33 - - 2.86 10.78
Test-6 COVID-19 100.0 98.75 - - 2.14 4.71
Code and files from our experiments are available at this link : https://github.com/
sayantanibasu/covid19-models.
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CHAPTER 6: CONCLUSION
The COVID-19 pandemic had an adverse effect worldwide and led to a massive number
of infections and deaths. All countries took important mitigation measures to fight the
pandemic by enforcing social distancing, lockdowns, mandatory face coverings, frequent
sanitizing, and a variety of other mitigation measures. In this thesis, we study the dynamics
and genetics of COVID-19. In order to study the dynamics of COVID-19, we propose an
LSTM based model that can be trained on cumulative numbers of COVID-19 confirmed
cases and deaths. Our proposed model predicts and provides useful insights at both the
country and county levels. We have obtained results at three points of time – May 11, June
10, and June 30 for the United States of America and some other globally affected regions.
We also quantitatively evaluate the degree to which mitigation measures are working based
on the rate of infections and deaths. This can aid countries and counties while deciding on
phased reopening and mitigation strategies. In order to study the genetics of COVID-19, we
propose an alignment-free MLP based model that is trained at various taxonomic levels to
study the ‘genetic language’ and classify genetic sequences of COVID-19 at each taxonomic
level. Our proposed approach shows higher cross-validated accuracy and reduced time on
several tests and performs at par with the baseline model in identifying COVID-19 genetic
sequences. We hope that our proposed work and results on COVID-19 will help contribute
to society.
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